Results 21 to 30 of about 2,671,764 (310)

Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States

Human Vaccines & Immunotherapeutics, 2021
The Advisory Committee on Immunization Practices (ACIP) recommended catch-up 9-valent Human Papillomavirus (HPV) vaccination through age 26 years, and shared clinical decision-making for adults aged 27–45 years, compared with catch-up through age 26 ...
Vincent Daniels, Vimalanand S. Prabhu, Cody Palmer, Salome Samant, Smita Kothari, Craig Roberts, Elamin Elbasha   +6 more
doaj   +1 more source

Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis

BMC Infectious Diseases, 2021
Background Varicella is a highly contagious infection that typically occurs in childhood. While most cases have a generally benign outcome, infection results in a considerable healthcare burden and serious complications may occur.
Jessica Vandenhaute, Elyonore Tsakeu, Pierre Chevalier, Manjiri Pawaskar, Goran Benčina, Jan Vertriest   +5 more
doaj   +1 more source

Real-World Evidence of CAR T-cell Therapy in Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma.

Blood, 2023
The emergence of chimeric antigen receptor (CAR) T-cell therapy has changed the treatment landscape for diffuse large B-cell lymphoma (DLBCL), however, real-world evidence reporting outcomes among older patients treated with CAR T-cell therapy is limited.
D. Chihara, L. Liao, J. Tkacz, Anjali Franco, B. Lewing, K. Kilgore, L. Nastoupil, Lei Chen   +7 more
semanticscholar   +1 more source

Clinical, economic, and humanistic burden of community acquired pneumonia in Europe: a systematic literature review

Expert Review of Vaccines, 2023
Background Community-acquired pneumonia (CAP) is an infectious lung inflammation contracted outside the hospital. CAP is a leading cause of death among young children, elderly, and immunocompromised persons. Incidence can reach 14 cases/1,000 adults.
Eleana Tsoumani, John A Carter, Stina Salomonsson, Jennifer M Stephens, Goran Bencina   +4 more
doaj   +1 more source

Harnessing Real-World Evidence to Advance Cancer Research

Current Oncology, 2023
Randomized controlled trials (RCTs) form a cornerstone of oncology research by generating evidence about the efficacy of therapies in selected patient populations.
Monica Tang, Sallie-Anne Pearson, R. Simes, Boon H. Chua   +3 more
semanticscholar   +1 more source

Real‐world evidence in hepatocellular carcinoma [PDF]

Liver International, 2021
AbstractReal‐world evidence includes all health‐related information, such as electronic health records, insurance claims, pharmacy records and wearables that are obtained outside of clinical trials. These data can provide critical insights into the natural history of disease and evaluate the safety and effectiveness of treatment regimens used in ...
Andrea R, Mospan, Heather L, Morris, Michael W, Fried   +2 more
openaire   +2 more sources

Real-world Evidence of Axicabtagene Ciloleucel for the Treatment of Large B-Cell Lymphoma in the United States

Transplantation and Cellular Therapy, 2022
Background: Axicabtagene ciloleucel (axi-cel) is a standard-of-care for relapsed or refractory (r/r) large B-cell lymphoma (LBCL) with two or more lines of prior therapy.
C. Jacobson, F. Locke, Long Ma, Julius Asubonteng, Zhen-Huan Hu, T. Siddiqi, Saira S. Ahmed, A. Ghobadi, D. Miklos, Yi-Chung Lin, M. Perales, M. Lunning, Megan M. Herr, B. Hill, S. Ganguly, Hua Dong, S. Nikiforow, M. Hooper, J. Kawashima, Hairong Xu, M. Pasquini   +20 more
semanticscholar   +1 more source

Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: A systematic literature review

Human Vaccines & Immunotherapeutics, 2022
National Immunization Technical Advisory Groups (NITAGs) and Health Technology Assessment (HTA) agencies evaluate the value of vaccines and provide decision-making authorities with recommendations.
Goran Bencina, Hanna Fues Wahl, Eleana Tsoumani, Stina Salomonsson   +3 more
doaj   +1 more source

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative

Journal of Clinical Oncology, 2022
PURPOSE To provide real-world evidence on risks and outcomes of breakthrough COVID-19 infections in vaccinated patients with cancer using the largest national cohort of COVID-19 cases and controls. METHODS We used the National COVID Cohort Collaborative (
Qianqian Song, Benjamin Bates, Y. R. Shao, Fang-Chi Hsu, Feifan Liu, V. Madhira, A. Mitra, Timothy Bergquist, R. Kavuluru, Xiaochun Li, Noha Sharafeldin, Jing Su, U. Topaloglu   +12 more
semanticscholar   +1 more source

Short and long-term costs among women experiencing preterm labour or preterm birth: the German experience

BMC Pregnancy and Childbirth, 2018
Background Preterm labour and birth (PTL/PTB) is characterised by major health and developmental risks for children, life–changing consequences for their families, and substantial healthcare and economic challenges for wider society.
Shibani Pokras, Jeanne Pimenta, Evie Merinopoulou, Dimitra Lambrelli   +3 more
doaj   +1 more source